about
Inhibition of spinal microglial cathepsin S for the reversal of neuropathic painAnalysis of the Role of CX3CL1 (Fractalkine) and Its Receptor CX3CR1 in Traumatic Brain and Spinal Cord Injury: Insight into Recent Advances in Actions of Neurochemokine Agents.CX3CL1 (fractalkine) protein expression in normal and degenerating mouse retina: in vivo studies.CX3CL1, a chemokine finely tuned to adhesion: critical roles of the stalk glycosylation and the membrane domain.Genetic background of psoriasisProgesterone Attenuates Microglial-Driven Retinal Degeneration and Stimulates Protective Fractalkine-CX3CR1 Signaling.Analysis of TCR/CD3 Recycling at the Immune Synapse.Cellular and subcellular evidence for neuronal interaction between the chemokine stromal cell-derived factor-1/CXCL 12 and vasopressin: regulation in the hypothalamo-neurohypophysial system of the Brattleboro rats.Fractalkine-CX3CR1 signaling is critical for progesterone-mediated neuroprotection in the retina.The chemokine CX3CL1 promotes trafficking of dendritic cells through inflamed lymphatics.Role of CX3CL1 in Diseases.Constitutive endocytosis of the chemokine CX3CL1 prevents its degradation by cell surface metalloproteases.Functional adhesiveness of the CX3CL1 chemokine requires its aggregation. Role of the transmembrane domainCX3CR1 is expressed by prostate epithelial cells and androgens regulate the levels of CX3CL1/fractalkine in the bone marrow: potential role in prostate cancer bone tropismThromboxane prostanoid receptor stimulation induces shedding of the transmembrane chemokine CX3CL1 yet enhances CX3CL1-dependent leukocyte adhesion.CX3CR1 deficiency induces an early protective inflammatory environment in ischemic mice.
P2860
Q28572461-A2603A36-6C82-4FB2-9E45-5C4384FF0F97Q30360306-8E60D9A3-C358-4517-83AC-704DC9F094DBQ34142149-489F39FC-26BA-467D-9D5A-A5FDEA2435C1Q34698709-761B2456-6C1F-4768-B581-204C84855D5CQ34747478-FAD7F2EC-092F-43A7-B657-284C47029236Q36182897-55137D02-7F3A-4C88-B80C-9DF6ECC09143Q36296169-AB46AF67-8753-4426-ACAA-2CBD08F11DFAQ36372561-96636521-CF88-4100-B394-9E2717D685BAQ37652175-34421D81-63E0-4F27-AB29-5B60A120C3AEQ38424659-CD98C4A0-EA5B-4DE9-BE6F-558798AFDD3AQ38813214-3ACD5120-B24A-4D78-A526-778AC5A410ADQ39805177-0994A842-B508-47A5-9744-12368E35C4F1Q39947412-ECBDE50A-92C1-4B4B-B9CB-C338D1A29025Q40002581-D92092BC-8FC4-4129-A036-798F671C3CB4Q43125926-3CD05BF1-D378-41F1-868B-A356740C27A3Q44762457-6CE75A01-5799-40AE-B387-3F3F316EE445
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Recycling of the membrane-anchored chemokine, CX3CL1.
@en
type
label
Recycling of the membrane-anchored chemokine, CX3CL1.
@en
prefLabel
Recycling of the membrane-anchored chemokine, CX3CL1.
@en
P2093
P2860
P356
P1476
Recycling of the membrane-anchored chemokine, CX3CL1.
@en
P2093
Alan M Fong
Dhavalkumar D Patel
Guang-Ying Liu
Lisa A Robinson
Nicolas Touret
R Todd Alexander
Vathany Kulasingam
P2860
P304
19858-19866
P356
10.1074/JBC.M413073200
P407
P577
2005-03-16T00:00:00Z